Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding Subsidiary – GlobeNewswire

Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding Subsidiary  GlobeNewswire

SAN DIEGO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has received a Notice of ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.